Hemab Therapeutics Holdings, Inc. (COAG)
NASDAQ: COAG · Real-Time Price · USD
41.19
-0.03 (-0.07%)
At close: Sep 18, 2026, 4:00 PM EDT
41.19
0.00 (0.00%)
After-hours: Sep 18, 2026, 4:16 PM EDT
COAG Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, COAG stock has a consensus rating of "Strong Buy" and an average price target of $61.2. The average 1-year stock price forecast is 48.58% higher than the current stock price, while the lowest is $58 (+40.81%) and the highest is $65 (+57.81%).
Price Target: $61.2 (+48.58%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 12, 2026.
Analyst Ratings
The average analyst rating for COAG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $55 → $64 | Buy | Maintains | $55 → $64 | +55.38% | Aug 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $52 → $60 | Buy | Reiterates | $52 → $60 | +45.67% | Aug 11, 2026 |
| Goldman Sachs | Goldman Sachs | Buy Maintains $36 → $46 | Buy | Maintains | $36 → $46 | +11.68% | Jul 14, 2026 |
| Jefferies | Jefferies | Buy Maintains $39 → $47 | Buy | Maintains | $39 → $47 | +14.11% | Jul 13, 2026 |
| Evercore ISI | Evercore ISI | Buy Initiates $50 | Buy | Initiates | $50 | +21.39% | May 26, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.10
EPS Next Year
-2.54
from -3.10
EPS and Forward PE are based on non-GAAP adjusted numbers.